These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1932765)

  • 1. Effects of buflomedil on microvascular disorders in diabetic patients.
    Le Dévéhat C; Vimeux M; Bondoux G; Khodabandehlou T
    Blood Vessels; 1991; 28 Suppl 1():38-43. PubMed ID: 1932765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication.
    Diamantopoulos EJ; Grigoriadou M; Ifanti G; Raptis SA
    Int Angiol; 2001 Dec; 20(4):337-44. PubMed ID: 11782701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of buflomedil perfusion on peripheral tissue oxygenation during transluminal angioplasty in patients with advanced arteriopathy of the lower limbs].
    Joffre F; Meites G; Rousseau H; Staffin C; Allaert FA; Pelat P
    Ann Radiol (Paris); 1994; 37(3):239-44. PubMed ID: 8092756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between hemorheological and microcirculatory abnormalities in diabetes mellitus.
    Le Devehat C; Khodabandehlou T; Vimeux M
    Diabete Metab; 1994; 20(4):401-4. PubMed ID: 7843471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nuclear medicine studies of tissue concentration and hemodynamic effects of retrograde intravenous pressure infusions].
    Partsch H; Jochmann W; Mostbeck A; Hirschl M
    Wien Med Wochenschr; 1993; 143(7-8):172-6. PubMed ID: 8397459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo-controlled study of the effects of intravenous Buflomedil on foot skin microcirculation in patients with severe intermittent claudication.
    Van den Brande P; Maurel A
    Angiology; 1998 Feb; 49(2):105-14. PubMed ID: 9482510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of the vasoactive drug buflomedil in arterial occlusive disease].
    Racenberg J; Intaglietta M; Messmer K
    Fortschr Med; 1982 Nov; 100(41):1926-30. PubMed ID: 7152426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemorheologic therapy applications in coronary heart disease].
    Leschke M; Motz W; Strauer BE
    Wien Med Wochenschr; 1986; 136 Spec No():17-24. PubMed ID: 3825169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Digital blood flow in peripheral vascular diseases. Action of drugs: buflomedil].
    Frausini G; Rotatori P; Gaggi S; Barone A; Pupita F
    Minerva Cardioangiol; 1988 Jun; 36(6):319-22. PubMed ID: 3211330
    [No Abstract]   [Full Text] [Related]  

  • 10. [Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride].
    Ciuffetti G; Mercuri M; Lombardini R; Palazzetti D; Rizzo MT; Parnetti L
    Minerva Med; 1989 Nov; 80(11):1237-40. PubMed ID: 2689916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissular oxygenation and venoarteriolar reflex disturbances in diabetes mellitus: vasoregulator effect of Buflomedil.
    Le Devehat C; Khodabandehlou T; Vimeux M
    Clin Hemorheol Microcirc; 1999; 21(3-4):329-34. PubMed ID: 10711765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of buflomedil in diabetic retinopathy estimated by ocular fluorophotometry.
    Kjaergaard JJ; Ditzel J
    Int J Microcirc Clin Exp; 1987 Aug; 6(3):257-63. PubMed ID: 3308731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicentre clinical placebo-controlled study with buflomedil in the treatment of mild dementia of vascular origin.
    Cucinotta D; Aveni Casucci MA; Pedrazzi F; Ponari O; Capodaglio M; Valdina P; Toxiri I; Bartorelli L; Granata Q; Franzini C
    J Int Med Res; 1992 Apr; 20(2):136-49. PubMed ID: 1521670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired hemorheological properties in diabetic patients with lower limb arterial ischaemia.
    Le Devehat C; Khodabandehlou T; Vimeux M
    Clin Hemorheol Microcirc; 2001; 25(2):43-8. PubMed ID: 11790869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of buflomedil on blood viscosity parameters in insulin-dependent diabetic patients: a preliminary study.
    Van Acker K; Rillaerts E; De Leeuw I
    Biomed Pharmacother; 1989; 43(3):219-22. PubMed ID: 2775859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of buflomedil on erythrocyte deformability.
    Dormandy JA; Ernst E
    Angiology; 1981 Oct; 32(10):714-6. PubMed ID: 7034592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacoclinical study of the action of vinburnin versus placebo: study of the hemodynamic, microcirculatory and rheological effects in angiopathy of the lower limbs in diabetes mellitus.
    Le Devehat C; Vimeux M
    Int Angiol; 1989; 8(1):57-61. PubMed ID: 2671200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood fluidity in essential hypertension, arterial occlusive disease and diabetic angiopathies].
    Sternitzky R; Hänsgen K; Podhaisky H
    Z Gesamte Inn Med; 1991 Nov; 46(16):610-4. PubMed ID: 1792802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microcirculatory changes in patients with primary Raynaud's phenomenon after treatment with buflomedil.
    Jacobs MJ; Lemmens HA
    Int J Microcirc Clin Exp; 1985; 4(1):63-8. PubMed ID: 3886577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of microcirculation abnormalities in sickle cell patients upon buflomedil treatment.
    Bachir D; Maurel A; Beuzard Y; Razavian M; Kraiem A; Portos JL; Galacteros F
    Microvasc Res; 1993 Nov; 46(3):359-73. PubMed ID: 8121319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.